Sphingosine 1-phosphate in renal diseases

Cellular Physiology and Biochemistry

Volumn 31, Issue 6, 2013, Pages 745-760

  Koch, Alexander ^a,b   Pfeilschifter, Josef ^a   Huwiler, Andrea ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Diabetic nephropathy; Glomerulonephritis; Ischemia reperfusion injury; Kidney disease; Sphingosine 1 phosphate; Wilms tumor

Indexed keywords

2 AMINO 2 [2 [4 (3 BENZYLOXYPHENYLTHIO) 2 CHLOROPHENYL]ETHYL] 1,3 PROPANEDIOL; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; FINGOLIMOD; RECOMBINANT ENZYME; RECOMBINANT SPHINGOSINE 1 PHOSPHATE LYASE; RETINOIC ACID; SONEPCIZUMAB; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; KIDNEY; KIDNEY CELL; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY TUBULE CELL; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; PATHOGENESIS;

EID: 84878373903     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000350093     Document Type: Review

References (98)

1. Ghosh TK, Bian J, Gill DL: Intracellular calcium release mediated by sphingosine derivates in cells. Science 1990;248:1653-1656.
2. Zhang H, Desai NN, Murphey JM, Spiegel S: Increases in phosphatidic acid levels accompany sphingosine-stimulated proliferation of quiescent Swiss 3T3 cells. J Biol Chem 1990;65:21309-21316. (Pubitemid 120014154)
3. Zhang H, Desai NN, Olivera A, Seki T, Brooker G, Spiegel S: Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 1991;114:155-167. (Pubitemid 21909788)
4. Stoffel W, Heimann G, Hellenbroich B: Sphingosine kinase in blood platelets. Hoppe Seylers Z Physiol Chem 1973;354:562-566.
5. Alemany R, van Koppen CJ, Danneberg K, Ter Braak M, Meyer Zu Heringdorf D: Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch Pharmacol 2007;374:413-428. (Pubitemid 46215289)
6. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S: Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009;325:1254-1257.
7. Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T, Milstien S, Spiegel S: Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 2010;465:1084-1088.
8. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S: Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 2000;275:19513-19520. (Pubitemid 30441543)
9. Nava VE, Lacana E, Poulton S, Liu H, Sugiura M, Kono K, Milstien S, Kohama T, Spiegel S: Functional characterization of human sphingosine kinase-1. FEBS Lett 2000;473:81-84. (Pubitemid 30235190)
10. Katsuma S, Hada Y, Ueda T, Shiojima S, Hirasawa A, Tanoue A, Takagaki K, Ohgi T, Yano J, Tsujimoto G: Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. Genes Cells 2002;7:1217-1230. (Pubitemid 36024598)
11. Gennero I, Fauvel J, Niéto M, Cariven C, Giats F, Briand-Mésange F, Chap H, Salles JP: Apoptotic effects of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density. J Biol Chem 2002;277:12724-12734. (Pubitemid 34952633)
12. Klawitter S, Hofmann LP, Pfeilschifter J, Huwiler A: Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity. Br J Pharmacol 2007;150:271-280. (Pubitemid 46221036)
13. Hofmann LP, Ren S, Schwalm S, Pfeilschifter J, Huwiler A Sphingosine kinase 1 and 2 regulate the capacity of mesangial cells to resist apoptotic stimuli in an opposing manner. Biol Chem 2008;389:1399-1407.
14. Pfeilschifter J: Cross-talk between transmembrane signalling systems: a prerequisite for the delicate regulation of glomerular haemodynamics by mesangial cells. Eur J Clin Invest 1989;19:347-361. (Pubitemid 19203582)
15. Pfeilschifter J: Mesangial cells orchestrate inflammation in the renal glomerulus. News Physiol Sci 1994;9:271-276.
16. Kerjaschki D: Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001;108:1583-1587. (Pubitemid 33144868)
17. Pavenstädt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 2003;83:253-307. (Pubitemid 36459882)
18. 2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells. Kidney Int 1998;54:1470-1483.
19. Hanafusa N, Yatomi Y, Yamada K, Hori Y, Nangaku M, Okuda T, Fujita T, Kurokawa K, Fukagawa M: Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. Nephrol Dial Transplant 2002;17:580-586. (Pubitemid 34308811)
20. Yatomi Y, Yamamura S, Ruan F, Igarashi Y: Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatic acid. J Biol Chem 1997;272:5291-5297. (Pubitemid 27090092)
21. Olivera A, Spiegel S: Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 1993;365:557-560. (Pubitemid 23317779)
22. Kleuser B, Maceyka M, Milstien S, Spiegel S: Stimulation of nuclear sphingosine kinase activity by platelet-derived growth factor. FEBS Lett 2001;503:85-90. (Pubitemid 32769961)
23. Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, Sankala H, Payne SG, Bektas M, Ishii I, Chun J, Milstien S, Spiegel S: Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 2003;278:40330-40336. (Pubitemid 37248601)
24. Igarashi N, Okada T, Hayashi S, Fujita T, Jahangeer S, Nakamura S: Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 2003;278:46832-46839. (Pubitemid 37452263)
25. Förster A, Emmler T, Schwalm S, Ebadi M, Meyer zu Heringdorf D, Nieuwenhuis B, Kleuser B, Huwiler A, Pfeilschifter J: Glucocorticoids protect renal mesangial cells from apoptosis by increasing cellular sphingosine-1- phosphate. Kidney Int 2010;77:870-879.
26. Koch A, Völzke A, Wünsche C, Meyer Zu Heringdorf D, Huwiler A, Pfeilschifter J: Thiazolidinedione dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells. Br J Pharmacol 2012;166:1018-1032.
27. Sanchez T, Hla T: Structural and functional characteristics of S1P receptors. J Cell Biochem 2004;92:913-922. (Pubitemid 44264241)
28. Meyer zu Heringdorf D, Lass H, Kuchar I, Lipinski M, Alemany R, Rümenapp U, Jakobs KH: Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors. Eur J Pharmacol 2001;414:145-154. (Pubitemid 32181881)
29. Katsuma S, Hada Y, Shiojima S, Hirasawa A, Tanoue A, Takagaki K, Ohgi T, Yano J, Tsujimoto G: Transcriptional profiling of gene expression patterns during sphingosine 1-phosphate-induced mesangial cell proliferation. Biochem Biophys Res Commun 2003;300:577-584. (Pubitemid 38375846)
30. Xin C, Ren S, Kleuser B, Shabahang S, Eberhardt W, Radeke H, Schäfer-Korting M, Pfeilschifter J, Huwiler A: Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-β-induced cell responses. J Biol Chem 2004;279:35255-35262. (Pubitemid 39100522)
31. Sauer B, Vogler R, von Wenckstern H, Fujii M, Azano MB, Glick AB, Schäfer-Korting M, Roberts AB, Kleuser B: Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem 2004;279:38471-38479. (Pubitemid 39295999)
32. Radeke HH, von Wenckstern H, Stoidtner K, Sauer B, Hammer S, Kleuser B: Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol 2005;174:2778-2786. (Pubitemid 40279694)
33. Ren S, Babelova A, Moreth K, Xin C, Eberhardt W, Doller A, Pavenstädt H, Schaefer L, Pfeilschifter J, Huwiler A: Transforming growth factor-β2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-β2 by impeding CTGF expression. Kidney Int 2009;76:857-867.
34. Xin C, Ren S, Eberhardt W, Pfeilschifter J, Huwiler A: The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signaling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells. Br J Pharmacol 2006;147:164-174. (Pubitemid 43151564)
35. Ancellin N, Hla T: Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 1999;274:18997-19002.
36. Katsuma S, Ruike Y, Yano T, Kimura M, Hirasawa A, Tsujimoto G: Transcriptional regulation of connective tissue growth factor by sphingosine 1-phosphate in rat cultured mesangial cells. FEBS Lett 2005;579:2576-2582. (Pubitemid 40615661)
37. Li MH, Sanchez T, Pappalardo A, Lynch KR, Hla T, Ferrer F: Induction of the anti-proliferative connective tissue growth factor expression in Wilms tumor cells by sphingosine 1-phosphate receptor 2. Mol Cancer Res 2008;6:1649-1656.
38. Brinkmann V, Davies MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002;277:21453-21457. (Pubitemid 34952287)
39. Qiao L, Kozikowski AP, Olivera A, Spiegel S: Synthesis and evaluation of a photolyzable derivative of sphingosine 1-phosphate-caged SPP. Bioorg Med Chem Lett 1998;8:711-714. (Pubitemid 28160026)
40. Lan T, Liu W, Xie X, Xu S, Huang K, Peng J, Shen X, Liu P, Wang L, Xia P, Huang H: Sphingosine kinase-1 pathway mediates high glucose-induced fibroectin expression in glomerular mesangial cells. Mol Endocrinol 2011;25:2094-2105.
41. Venkatachalam MA, Bernard DB, Donohoe JF, Levinsky NG: Ischemic damage and repair in the rat proximal tubule: differences among the S1, S2 and S3 segments. Kidney Int 1978;14:31-49. (Pubitemid 8396236)
42. Lieberthal W, Nigam SK: Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 1998;275:623-631.
43. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B: HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994;45:48-57. (Pubitemid 24045991)
44. Kim M, Kim M, Kim N, D'Agati VD, Emela CW Sr, Lee HT: Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. Am J Physiol Renal Physiol 2007;293:F1827-F1835. (Pubitemid 350179608)
45. Kim M, Kim M, Park SW, Pitson SM, Lee TH: Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation. Am J Nephrol 2009;31:353-362.
46. Lee HT, Kim M, Kim J, Kim N, Emala CW: TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis. Am J Nephrol 2007;27:416-424. (Pubitemid 47077206)
47. Song JH, Kim M, Park SW, Chen SWC, Pitson SM, Lee TH: Isoflurane via TGF-β1 release increases caveolae formation and organizes sphingosine kinase signaling in renal proximal tubules. Am J Physiol Renal Physiol 2010;298:1041-1050.
48. Bajwa A, Jo SK, Ye H, Huang L, Dondeti KR, Rosin DL, Haase VH, Macdonald TL, Lynch KR, Okusa MD: Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol 2010;21:955-965.
49. Park WS, Kim M, Kim M, D'Agati VD, Lee HT: Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine1-1phosphate1 receptor activation. Kidney Int 2011;80:1315-1327.
50. Park WS, Kim M, Brown KM, D'Agati VD, Lee HT: Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2012;23:266-280.
51. Bischoff A, Czyborra P, Fetscher C, Meyer zu Heringdorf D, Jakobs KH, Michel MC: Sphingosine-1-phosphate and sphingosylphosphorylcholine constricts renal and mesenteric microvessels in vitro. Br J Pharmacol 2000;130:1871-1877. (Pubitemid 30655799)
52. Bischoff A, Czyborra P, Meyer zu Heringdorf D, Jakobs KH, Michel MC: Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol 2000;130:1878-1883. (Pubitemid 30655800)
53. Bischoff A, Meyer zu Heringdorf D, Jakobs KH, Michel MC: Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats. Br J Pharmacol 2001;132:1925-1933. (Pubitemid 32397985)
54. Jackson EK: Role of sphingosine-1-phosphate in the renal medulla. Am J Physiol Renal Physiol 2011;301:33-34.
55. Zhu Q, Xia M, Wang Z, Li PL, Li N: A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate. Am J Physiol Renal Physiol 2011;301:F35-F41.
56. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA: Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 2006;9:225-238. (Pubitemid 43357948)
57. O'Brien N, Jones ST, Williams DG, Cunningham HB, Moreno K, Visentin B, Gentile A, Vekich J, Shestowsky W, Hiraiwa M, Matteo R, Cavalli A, Grotjahn D, Grant M, Hansen G, Campbell MA, Sabbadini R: Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. J Lipid Res 2009;50:2245-2257.
58. Caballero S, Swaney J, Moreno K, Afzal A, Kielczewski J, Stoller G, Cavalli A, Garland W, Hansen G, Sabbadini R, Grant MB: Anti-sphingosine-1- phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp Eye Res 2009;88:367-377.
59. Huwiler A, Bourquin F, Kotelevets N, Pastukhov O, Capitani G, Grütter MG, Zangemeister-Wittke U: A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for targeting hyperproliferative disorders. PLoS One 2011;6:e22436.
60. Schena FP, Gesualdo L: Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 2005;16:S30-S33. (Pubitemid 41725079)
61. Breyer MD, Böttinger E, Brosius III FC, Coffman TM, Harris RC, Heilig CW, Sharma K: Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005;16:27-45. (Pubitemid 43073154)
62. Geoffroy K, Troncy L, Wiernsperger N, Lagarde M, El Bawab S: Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. FEBS Lett 2005;579:1249-1254. (Pubitemid 40248695)
63. Lan T, Shen X, Liu P, Liu W, Xu S, Xie X, Jiang Q, Li W, Huang H: Berberine ameliorates renal injury in diabetic C57BL/6 mice: involvement of suppression of Sphk-S1P signaling pathway. Arch Biochem Biophys 2010;502:112-120.
64. Imasawa T, Kitamura H, Ohkawa R, Satoh Y, Miyashita A, Yatomi Y: Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy. Exp Toxicol Pathol 2010;62:53-60. (Pubitemid 47284808)
65. Awad AS, Rouse MD, Khutsishvili K, Huang L, Bolton WK, Lynch KR, Okusa MD: Chronic sphingosine 1-phosphate receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int 2011;79:1090-1098.
66. Seymour AE: Glomerulonephritis: approaches to classification. Pathology 1985;17:225-238. (Pubitemid 16251022)
67. Peters H, Martini S, Wang Y, Shimizu F, Kawachi H, Krämer S, Neumayer HH: Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis. Kidney Int 2004;66:1434-1443. (Pubitemid 39298375)
68. Martini S, Krämer S, Loof T, Wang-Rosenke Y, Daig U, Budde K, Neumayer HH, Peters H: S1P modulator FTY720 limits matrix expansion in acute anti-thy 1 mesangioproliferative glomerulonephritis. Am J Physiol Renal Physiol 2007;292:F1761-F1770. (Pubitemid 47105366)
69. Lebleu VS, Sugimoto H, Miller CA, Gattone VH 2nd, Kalluri R: Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease. Lab Invest 2008;88:284-292. (Pubitemid 351311280)
70. Sui M, Zhou J, Xie R, Liu X, Mu S, Jia X, Ma J, Wu H: The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis. Mol Biol Rep 2011;39:389-397.
71. Wenderfer SE, Stepkowski SM, Braun MC: Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist. Kidney Int 2008;74:1319-1326.
72. Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E: KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation 2005;111:222-229. (Pubitemid 40139735)
73. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lympho-proliferative diseases. Annu Rev Immunol 1991;9:243-269.
74. Chatauret N, Thuillier R, Hauet T: Preservation strategies to reduce ischemic injury in kidney transplantation: pharmacological and genetic approaches. Curr Opin Organ Transplant 2011;16:180-187.
75. Zager RA, Iwata M, Conrad DS, Burkhart KM, Igarashi Y: Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int 1997;52:60-70. (Pubitemid 27321815)
76. Kalhorn T, Zager RA: Renal cortical ceramide patterns during ischemic and toxic injury: assessments by HPLC-mass spectrometry. Am J Physiol 1999;277:F723-733.
77. Zager RA, Conrad DS, Burkhart K: Ceramide accumulation during oxidant renal tubular injury: mechanisms and potential consequences. J Am Soc Nephrol 1998;9:1670-1680.
78. Jo SK, Bajwa A, Ye H, Vergis AL, Awad AS, Kharel Y, Lynch KR, Okusa MD: Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int 2009;75:167-175.
79. Jin ZQ, Zhang J, Huang Y, Hoover HE, Vessey DA, Karliner JS: A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. Cardiovasc Res 2007;76:41-50. (Pubitemid 47362044)
80. Vessey DA, Li L, Jin ZQ, Kelley M, Honbo N, Zhang J, Karliner JS: A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid Med Cell Longev 2011;2011:961059.
81. Troncoso P, Ortíz M, Martínez L, Kahan BD: FTY 720 prevents ischemic reperfusion damage in rat kidneys. Transplant Proc 2001;33:857-859. (Pubitemid 32237658)
82. Awad AS, Ye H, Huang L, Li L, Foss FW Jr, Macdonald TL, Lynch KR, Okusa MD: Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006;290:F1516-F1524. (Pubitemid 43830779)
83. Lien YH, Yong KC, Cho C, Igarashi S, Lai LW: S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 2006;69:1601-1608.
84. Lai LW, Yong KC, Igarashi S, Lien YH: A sphingosine-1-phsophate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int 2007;71:1223-1231. (Pubitemid 46884247)
85. Ysebaert DK, De Greef KE, De Beuf A, Van Rompay AR, Vercauteren S, Persy VP, De Broe ME: T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004;66:491-496. (Pubitemid 38981984)
86. Lee SY, Kim DH, Sung SA, Kim MG, Cho WY, Kim HK, Jo SK: Sphingosine-1-phosphate reduces hepatic ischemia/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice. Nephrology 2011;16:163-173.
87. Sola A, Weigert A, Jung M, Vinuesa E, Brecht K, Weis N, Brüne B, Borregaard N, Hotter G: Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration. J Pathol 2011;225:597-608.
88. Varan A: Wilms' tumor in children: an overview. Nephron Clin Pract 2008;108:83-90.
89. Pyne NJ, Pyne S: Sphingosine 1-phosphate and cancer. Nat Rev Cancer 2010;10:489-503.
90. Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, Mertens F, Graf N, Eilers M, Gessler M: Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 2006;118:1954-1962.
91. Simoni D, Tolomeo M: Retinoids, apoptosis and cancer. Curr Pharm Des 2001;7:1823-1837. (Pubitemid 32998338)
92. Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M: All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene 2005;24:5246-5251. (Pubitemid 41192441)
93. Jacobson A, Cunningham JL: Connective tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue Repair 2012;5:S8.
94. Li MH, Sanchez T, Pappalardo A, Lynch KR, Hla T, Ferrer F: Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res 2008;6:1649-1656.
95. Li MH, Sanchez T, Yamase H, Hla T, Oo ML, Pappalardo A, Lynch KR, Lin CY, Ferrer F: S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. Cancer Lett 2009;276:171-179.
96. 2 signaling induces cyclooxygenase-2 expression in Wilms tumor. J Urol 2009;181:1347-1352.
97. Khan Z, Khan N, Tiwari RP, Sah NK, Prasad GB, Bisen PS: Biology of Cox-2: an application in cancer therapeutics. Curr Drug Targtes 2011;12:1082-1093.
98. Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Bender JG, Kandel JJ, Yamashiro DJ: Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res 2006;66:4378-4384.